FTSE 100 news / Companies and sectors / GSK / 4 October 2026
GSK (GSK): news on Sunday 4 October 2026
+7.0 strongly positive
Coverage centred on GSK agreeing to acquire the ChImagen therapy for $750 million. The deal is read as a pipeline addition, so the tone leans modestly positive.
What drove it ChImagen acquisition pipeline expansion The 1 story Each headline's own score, strongest first. Links go to the publisher.
GSK: every day · Pharma and healthcare on 4 October 2026 · FTSE 100 overview for the day
← Saturday 3 October 2026 Monday 5 October 2026 → The scores rate the tone of news coverage, nothing more. They are not share-price data, forecasts or investment advice. A good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.
How it works: Each morning we gather headlines from Google News, Yahoo Finance and 49 UK business and trade-press RSS feeds. Claude Sonnet, an AI model, reads each one and decides whether it is really about the company; its own brands and subsidiaries count. It then scores the news, and we show that as a tone score from −10 (clearly bad for the company) to +10 (clearly good). Scores beyond ±6 are strong and rare. A company's day score is the model's overall read of its relevant coverage. Days run on UTC. Pages update at about 07:45 UK time.